We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Catumaxomab
Australian Public Assessment Report
Device/Product Name
Removab
Active ingredients
Catumaxomab
AusPAR Date
Published
Sponsor
Submission Number
PM-2010-03132-3-4
Submission Type
New chemical entity
Decision
Rejected